Cholinesterase Inhibitor Use in US Nursing Homes: Results from the National Nursing Home Survey
Cholinesterase Inhibitor Use in US Nursing Homes: Results from the National Nursing Home Survey
复制标题
DOI:
10.1111/j.1532-5415.2009.02552.x
复制
发表时间:
2009-12-01
影响因子:
6.3
通讯作者:
Rochon, Paula A.
中科院分区:
文献类型:
--
作者:
Seitz, Dallas P.;Gruneir, Andrea;Rochon, Paula A.
OBJECTTVES: To determine the frequency of cholinesterase inhibitor (ChEI) use in nursing home (NH) residents with dementia and examine correlates of ChEI use in this population.DESIGN: Cross-sectional study using the 2004 National Nursing Home Survey (NNHS).SETTING: A representative, stratified, random sample of U.S. NHs.PARTICIPANTS: All NNHS participants aged 65 and older with a chart diagnosis of dementia.MEASUREMENTS: Bivariate analyses to compare characteristics of NH residents with dementia according to ChEIs status and multivariable logistic regression to identify independent correlates of ChEI use.RESULTS: Almost half (49.1%) of NNHS participants had dementia, and 30.0% of those with dementia were receiving ChEIs. Donepezil accounted for 71% of all ChEI prescriptions. Multivariable logistic regression showed that ChEI use was independently associated with younger age (odds ratio (OR) = 0.42, 95% confidence interval (CI) = 0.28-0.64, aged >= 95 vs 65-74), less activity of daily living impairment (OR = 0.49, 95% CI = 0.42-0.58, severe vs mild impairment), greater use of antipsychotics (OR=1.33, 95% CI=1.16-1.54) and antidepressants (OR = 1.38, 95% CI = 1.20-1.59), and residence in NHs with more beds (OR = 1.52, 95% CI = 1.07-2.16, >= 200 beds vs